DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Personalized Health Planning in Shared Medical Appointments for Individuals With Type II Diabetes Pilot Study

Information source: Duke University
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Type II Diabetes

Intervention: Personalized Health Planning Shared Medical Appointment (Behavioral)

Phase: N/A

Status: Not yet recruiting

Sponsored by: Duke University

Official(s) and/or principal investigator(s):
Sharon Hull, MD MPH, Principal Investigator, Affiliation: Duke University

Overall contact:
Connor D Drake, MPA, Phone: 9197242129, Email: connor.drake@duke.edu

Summary

The primary aim of this study is to examine the feasibility of implementing an evidence based patient engagement strategy, known as personalized health planning (PHP), in the context of a a shared medical appointment (SMA) for individuals with type II diabetes in a primary care setting.

Clinical Details

Official title: Personalized Health Planning in Shared Medical Appointments for Individuals With Type II

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Primary outcome:

Feasibility measured using a patient satisfaction survey

Change in patient activation measured using the patient activation measure

Change in self-management of diabetes self-efficacy using the Diabetes Empowerment Scale

Change in diabetes self efficacy using the 1-item diabetes self-efficacy scale

Change in A1C using the A1C blood test

Secondary outcome:

Change in depression screening score using the Patient Health Questionnaire (PHQ-9)

Change in functional health and well-being using the short form health survey

Change in general self-rated health using the general self rated health survey (GSRH)

Change in health goal progress using a goal progress visual analog scale

change in body mass index using weight and height measurements

change in blood pressure using blood pressure measurement

Change in low-density lipoprotein cholesterol (LDL) using LDL measurement

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- A diagnosis of Type 2 diabetes within the last year

- A current patient at Duke Family Medicine.

- An A1C score greater than 7 and less than 14.

Exclusion Criteria:

- A diagnosis of Pre-diabetes

- A diagnosis of Type I diabetes

- Individuals with amputations as a result of their diabetes are excluded form this

study.

- Individuals with renal dialysis will not be included in this study.

Locations and Contacts

Connor D Drake, MPA, Phone: 9197242129, Email: connor.drake@duke.edu

Additional Information

Starting date: August 2015
Last updated: June 11, 2015

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017